Table 1. Clinical features of patients.
Clinical features | Training cohort (n=2,208) | Test cohort (n=922) |
---|---|---|
Age (years) | 73 [66, 79] | 74 [68, 80] |
Sex | ||
Male | 1,736 (78.62) | 708 (76.79) |
Female | 472 (21.38) | 214 (23.21) |
History of malignancy | ||
No | 1,662 (75.27) | 664 (72.02) |
Yes | 546 (24.73) | 258 (27.98) |
Pathology | ||
Epithelioid mesothelioma | 1,452 (65.76) | 624 (67.68) |
Sarcomatoid mesothelioma | 419 (18.98) | 151 (16.38) |
Biphasic mesothelioma | 337 (15.26) | 147 (15.94) |
T | ||
T1 | 696 (31.52) | 322 (34.92) |
T2 | 496 (22.46) | 182 (19.74) |
T3 | 409 (18.52) | 147 (15.94) |
T4 | 607 (27.49) | 271 (29.39) |
N | ||
N0 | 1,446 (65.49) | 614 (66.59) |
N1 | 118 (5.34) | 146 (15.84) |
N2 | 581 (26.31) | 143 (15.51) |
N3 | 63 (2.85) | 19 (2.06) |
M | ||
M0 | 1,835 (83.11) | 663 (71.91) |
M1 | 373 (16.89) | 259 (28.09) |
Surgery | ||
No | 1,396 (63.22) | 626 (67.90) |
Yes | 812 (36.78) | 296 (32.10) |
Radiotherapy | ||
No | 1,881 (85.19) | 795 (86.23) |
Yes | 327 (14.81) | 127 (13.77) |
Chemotherapy | ||
No | 951 (43.07) | 355 (38.50) |
Yes | 1,257 (56.93) | 567 (61.50) |
Survival time (months) | 10 [4, 22] | 8 [3, 16] |
Data are presented as median [interquartile range] or n (%).